Syk kinase as a treatment target for therapy in autoimmune diseases

被引：34
作者：
Kyttaris, Vasileios C. [1 ]
Tsokos, George C. [1 ]
机构：
[1] Harvard Univ, Sch Med, Harvard Inst Med, Beth Israel Deaconess Med Ctr,Div Rheumatol, Boston, MA 02115 USA
来源：
CLINICAL IMMUNOLOGY | 2007年 / 124卷 / 03期
关键词：
autoimmunity; rheumatoid arthritis; Syk kinase; Fc gamma receptor;
D O I：
10.1016/j.clim.2007.06.005
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Spleen tyrosine kinase (Syk) associates with a variety of immunoreceptors in myetoid and lymphoid cells. Syk initiates intracellular signaling once the receptor is engaged by its ligand. Blocking Syk may prove beneficial in interrupting the propagation of the abnormal immune response in both autoimmune and allergic diseases. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码：235 / 237
页数：3
相关论文
共 13 条
[1]  
BENHAMOU M, 1993, J BIOL CHEM, V268, P23318
[2]   Src and Syk kinases:: key regulators of phagocytic cell activation [J].
Berton, G ;
Mócsai, A ;
Lowell, CA .
TRENDS IN IMMUNOLOGY, 2005, 26 (04) :208-214
[3]  
Colgan J, 2007, CURR OPIN ALLERGY CL, V7, P51, DOI 10.1097/ACI.0b013e32801297e6
[4]  
Enyedy EJ, 2001, ARTHRITIS RHEUM, V44, P1114, DOI 10.1002/1529-0131(200105)44:5<1114::AID-ANR192>3.3.CO
[5]  
2-2
[6]   Role of ITAM-containing adapter proteins and their receptors in the immune system and bone [J].
Humphrey, MB ;
Lanier, LL ;
Nakamura, MC .
IMMUNOLOGICAL REVIEWS, 2005, 208 :50-65
[7]   The immunomodulatory adapter proteins DAP12 and Fc receptor γ-chain (FcRγ) regulate development of functional osteoclasts through the Syk tyrosine kinase [J].
Mócsai, A ;
Humphrey, MB ;
Van Ziffle, JAG ;
Hu, YM ;
Burghardt, A ;
Spusta, SC ;
Majumdar, S ;
Lanier, LL ;
Lowell, CA ;
Nakamura, MC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (16) :6158-6163
[8]   Progressive loss of Syk and abnormal proliferation in breast cancer cells [J].
Moroni, M ;
Soldatenkov, V ;
Li, Z ;
Ying, Z ;
Stoica, G ;
Gehan, E ;
Rashidi, B ;
Singh, B ;
Ozdemirli, M ;
Mueller, SC .
CANCER RESEARCH, 2004, 64 (20) :7346-7354
[9]  
POLLY RP, 2007, CLIN IMMUNOL, V124, P244
[10]   Drug therapy: Imatinib mesylate - A new oral targeted therapy. [J].
Savage, DG ;
Antman, KH .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (09) :683-693
12